Leukemia Research
Volume 29, Issue 2 , Pages 233-234 , February 2005

Neutrophilic eccrine hidradenitis induced by imatinib mesylate (Gleevec) therapy

Received 14 May 2004

References 

  1. Liu D, Seiter K, Mathews T, Madahar CJ, Ahmed T. Sweet's syndrome with CML cell infiltration of the skin in a patient with chronic-phase CML while taking imatinib mesylate. Leuk. Res. 2004;28(Suppl. 1):61–63
  2. Druker BJ, Talpaz M, Resta DJ, et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N. Engl. J. Med. 2001;344:1031–1037
  3. Brouard MC, Prins C, Mach-Pascual S, Saurat JH. Acute generalized exanthematous pustulosis associated with STI571 in a patient with chronic myeloid leukemia. Dermatology. 2001;203:57–59
  4. Hsiao LT, Chung HM, Lin JT, et al. Stevens–Johnson syndrome after treatment with STI571: a case report. Br. J. Haematol. 2002;117:620–622
  5. Gomez Vazquez M, Peteiro C, Toribio J. Neutrophilic eccrine hidradenitis heralding the onset of chronic myelogenous leukaemia. J. Eur. Acad. Dermatol. Venereol. 2003;17(3):328–330
  6. Bachmeyer C, Aractingi S. Neutrophilic eccrine hidradenitis. Clin. Dermatol. 2000;18(3):319–330

PII: S0145-2126(04)00222-X

doi: 10.1016/j.leukres.2004.05.015

Leukemia Research
Volume 29, Issue 2 , Pages 233-234 , February 2005

Article Tools